Combination of sintilimab, anlotinib and pegaspargase "sandwich" with radiotherapy in localized natural killer/T cell lymphoma: A multicenter, phase 2 study.

doi:10.1200/JCO.2021.39.15_suppl.7537

HFCAS OpenIR

	Combination of sintilimab, anlotinib and pegaspargase "sandwich" with radiotherapy in localized natural killer/T cell lymphoma: A multicenter, phase 2 study.
	Li, Zhiming ; Sun, Peng; Wang, Yu; Yang, Hang ; Li, Yajun ; Zhou, Hui ; Yang, Haiyan ; Zou, Liqun
	2021-05-20
发表期刊	JOURNAL OF CLINICAL ONCOLOGY
ISSN	0732-183X
DOI	10.1200/JCO.2021.39.15_suppl.7537
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000708120604134
出版者	LIPPINCOTT WILLIAMS & WILKINS
引用统计
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/126603
专题	中国科学院合肥物质科学研究院
作者单位	1.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China 2.Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China 3.Hunan Canc Hosp, Dept Lymphoma & Hematol, Changsha, Peoples R China 4.Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China 5.Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China 6.Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China 7.Sichuan Univ, West China Hosp, Chengdu, Peoples R China
推荐引用方式 GB/T 7714	Li, Zhiming,Sun, Peng,Wang, Yu,et al. Combination of sintilimab, anlotinib and pegaspargase "sandwich" with radiotherapy in localized natural killer/T cell lymphoma: A multicenter, phase 2 study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39.
APA	Li, Zhiming.,Sun, Peng.,Wang, Yu.,Yang, Hang.,Li, Yajun.,...&Zou, Liqun.(2021).Combination of sintilimab, anlotinib and pegaspargase "sandwich" with radiotherapy in localized natural killer/T cell lymphoma: A multicenter, phase 2 study..JOURNAL OF CLINICAL ONCOLOGY,39.
MLA	Li, Zhiming,et al."Combination of sintilimab, anlotinib and pegaspargase "sandwich" with radiotherapy in localized natural killer/T cell lymphoma: A multicenter, phase 2 study.".JOURNAL OF CLINICAL ONCOLOGY 39(2021).